skip to Main Content

Janssen Announces Unblinding of Phase 3 CARTITUDE-4 Study of CARVYKTI® (cilta-cel) as Primary Endpoint Met in Treatment of Patients with Relapsed and Refractory Multiple Myeloma #mmsm #cellulartherapy #CARTsm

An inspiration for the new year! Dr. Alex Herrera was on the @cityofhope "Expanding Hope" float in the #roseparade2023 . The mother of one of his patients walked alongside the float for 2.5 miles throwing him kisses to give him thanks and gratitude.

Excited that our efforts, led by @tal_sella and @AnnPartridgeMD, to study patients’ perspectives on testing for #CHIP is now published @BloodAdvances

Load More...
Back To Top